Chicago, Illinois, United States Synetro Group is the famous VC, which was founded in 2000. The company was established in North America in United States. The main office of represented VC is situated in the Chicago.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The higher amount of exits for fund were in 2014. The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 11 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2000. This Synetro Group works on 11 percentage points less the average amount of lead investments comparing to the other organizations.
Among the most successful fund investment fields, there are Marketing, Consumer Goods. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight dscout, Insurance Noodle. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 1-2 participants. The meaningful sponsors for the fund in investment in the same round are Beringea. In the next rounds fund is usually obtained by Venturion Capital, Mosaix Ventures, Beringea.
This organization was formed by Pete Georgiadis. Besides them, we counted 1 critical employee of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AHR Growth Partners | Chicago, Illinois, United States |
| Austin Impact Capital | Austin, Texas, United States |
| Brightstar Capital Partners | New York, New York, United States |
| Catcha Group | Kuala Lumpur, Malaysia |
| Cathay Capital Private Equity | France, Ile-de-France, Paris |
| Chrystal Capital | Mayfair, United Kingdom, Westminster |
| CountShop | - |
| DANNIX | Chicago, Illinois, United States |
| Iron Yard Ventures | Greenville, South Carolina, United States |
| Jazz Venture Partners | California, San Francisco, United States |
| Jiaxing Hongzhi | China, Jiaxing, Zhejiang |
| Kotobna | Egypt, Texas, United States |
| LearnStart | New York, New York, United States |
| Michelin | Auvergne, Auvergne-Rhône-Alpes, France |
| NavInfo | Beijing, Beijing, China |
| Pendopharm | Canada, Montreal, Quebec |
| Soridec | France, Languedoc-Roussillon, Montpellier |
| Startup Edmonton | Alberta, Canada, Edmonton |
| Toyo Tsushin Kogyo | Japan, Yamanashi, Yamanashi Prefecture |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TaskHuman | $20M | 21 Jun 2022 | California, United States | ||
Aramid Technologies | $2M | 08 Feb 2022 | Gilbert, Arizona, United States | ||
Lisa Health | 28 Jan 2022 | Oakland, California, United States | |||
WeSolv | 24 Jan 2022 | Chicago, Illinois, United States | |||
GoodTrust | $5M | 20 Dec 2021 | Palo Alto, California, United States | ||
Cellanome | $21M | 17 Dec 2021 | Redwood City, California, United States | ||
Manual | 21 Sep 2021 | London, England, United Kingdom | |||
Intelligencia | $12M | 10 Aug 2021 | New York, New York, United States | ||
Sharewell | 23 Jul 2021 | Tallinn, Harjumaa, Estonia |
– Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce risk, has raised $12M in order to continue to expand its product offering and customer base.
– Healthtech investor MTIP led the oversubscribed Series A round, joined by several of the company’s existing investors, including Big Pi Ventures and Synetro Group. ZS, a global professional services firm that leverages deep analytics and biopharmaceutical industry expertise to help companies and their customers thrive, has also participated in this round.
– The company’s founders, Dimitrios Skaltsas and Vangelis Vergetis, met while at McKinsey & Company, and have spent more than a decade in the intersection of clinical development, data science, and technology solutions.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TaskHuman | $20M | 21 Jun 2022 | California, United States | ||
Aramid Technologies | $2M | 08 Feb 2022 | Gilbert, Arizona, United States | ||
Lisa Health | 28 Jan 2022 | Oakland, California, United States | |||
WeSolv | 24 Jan 2022 | Chicago, Illinois, United States | |||
GoodTrust | $5M | 20 Dec 2021 | Palo Alto, California, United States | ||
Cellanome | $21M | 17 Dec 2021 | Redwood City, California, United States | ||
Manual | 21 Sep 2021 | London, England, United Kingdom | |||
Intelligencia | $12M | 10 Aug 2021 | New York, New York, United States | ||
Sharewell | 23 Jul 2021 | Tallinn, Harjumaa, Estonia |
